Click to Enlarge
Facebook
Twitter
The Financial Times leads on pharmaceuticals giant AstraZeneca drawing up plans to separate the Chinese arm of its global business and list it on the Hong Kong stock exchange – as a way of sheltering the company against mounting geopolitical tensions. The paper observes the moves shows the “significant restructuring” companies could be forced to undertake as they adapt to growing China–US friction. A person briefed on the plans explains to the paper it could insulate the firm from any moves by China to crackdown on foreign companies, by making it more plausibly a Chinese business.

Financial Times Front Page 19th of July 2024

Senior Democratic figures, including former President Obama and Speaker Pelosi, are raising doubts about President Biden’s viability in the upcoming White House race due to concerns over his re-election prospects and the impact on Senate seats.

Read More »